Citation: Eh. Estey et Mj. Keating, POSTREMISSION CHEMOTHERAPY FOR ACUTE MYELOID-LEUKEMIA, The New England journal of medicine, 332(5), 1995, pp. 334-334
Authors:
ESTROV Z
BLACK RA
SLEATH PR
HARRIS D
VAN Q
LAPUSHIN R
ESTEY EH
TALPAZ M
Citation: Z. Estrov et al., EFFECT OF INTERLEUKIN-1-BETA CONVERTING-ENZYME-INHIBITOR ON ACUTE MYELOGENOUS LEUKEMIA PROGENITOR PROLIFERATION, Blood, 86(12), 1995, pp. 4594-4602
Authors:
MARLTON P
CLAXTON DF
LIU P
ESTEY EH
BERAN M
LEBEAU M
TESTA JR
COLLINS FS
ROWLEY JD
SICILIANO MJ
Citation: P. Marlton et al., MOLECULAR CHARACTERIZATION OF 16P DELETIONS ASSOCIATED WITH INVERSION-16 DEFINES THE CRITICAL FUSION FOR LEUKEMOGENESIS, Blood, 85(3), 1995, pp. 772-779
Authors:
ZHAO L
CHANG KS
ESTEY EH
HAYES K
DEISSEROTH AB
LIANG JC
Citation: L. Zhao et al., DETECTION OF RESIDUAL LEUKEMIC-CELLS IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA BY THE FLUORESCENCE IN-SITU HYBRIDIZATION METHOD - POTENTIAL FOR PREDICTING RELAPSE, Blood, 85(2), 1995, pp. 495-499
Authors:
GHADDAR HM
PLUNKETT W
KANTARJIAN HM
PIERCE S
FREIREICH EJ
KEATING MJ
ESTEY EH
Citation: Hm. Ghaddar et al., LONG-TERM RESULTS FOLLOWING TREATMENT OF NEWLY-DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA WITH CONTINUOUS-INFUSION HIGH-DOSE CYTOSINE-ARABINOSIDE, Leukemia, 8(8), 1994, pp. 1269-1274
Citation: Jf. Seymour et al., INVESTIGATION OF KARYOTYPIC, MORPHOLOGIC AND CLINICAL-FEATURES IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA BLAST CELLS EXPRESSING THE NEURAL CELL-ADHESION MOLECULE (CD56), Leukemia, 8(5), 1994, pp. 823-826
Citation: Hm. Ghaddar et al., CYTOGENETIC EVOLUTION FOLLOWING THE TRANSFORMATION OF MYELODYSPLASTIC-SYNDROME TO ACUTE MYELOGENOUS LEUKEMIA - IMPLICATIONS ON THE OVERLAP BETWEEN THE 2 DISEASES, Leukemia, 8(10), 1994, pp. 1649-1653
Authors:
MARUYAMA F
STASS SA
ESTEY EH
CORK A
HIRANO M
INO T
FREIREICH EJ
YANG PR
CHANG KS
Citation: F. Maruyama et al., DETECTION OF AML1 ETO FUSION TRANSCRIPT AS A TOOL OF DIAGNOSING T(821) POSITIVE ACUTE MYELOGENOUS LEUKEMIA/, Leukemia, 8(1), 1994, pp. 40-45
Authors:
KANTARJIAN HM
OBRIEN S
SMITH T
ESTEY EH
BERAN M
PRETI A
PIERCE S
KEATING MJ
Citation: Hm. Kantarjian et al., ACUTE LYMPHOCYTIC-LEUKEMIA IN THE ELDERLY - CHARACTERISTICS AND OUTCOME WITH THE VINCRISTINE-ADRIAMYCIN-DEXAMETHASONE (VAD) REGIMEN, British Journal of Haematology, 88(1), 1994, pp. 94-100
Authors:
SEYMOUR JF
KURZROCK R
FREIREICH EJ
ESTEY EH
Citation: Jf. Seymour et al., 2-CHLORODEOXYADENOSINE INDUCES DURABLE REMISSIONS AND PROLONGED SUPPRESSION OF CD4(-CELL LEUKEMIA() LYMPHOCYTE COUNTS IN PATIENTS WITH HAIRY), Blood, 83(10), 1994, pp. 2906-2911
Citation: Pf. Thall et Eh. Estey, A BAYESIAN STRATEGY FOR SCREENING CANCER TREATMENTS PRIOR TO PHASE-IICLINICAL-EVALUATION, Statistics in medicine, 12(13), 1993, pp. 1197-1211
Citation: Eh. Estey et al., IDARUBICIN PLUS CONTINUOUS-INFUSION HIGH-DOSE CYTARABINE AS TREATMENTFOR PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA OR MYELODYSPLASTIC SYNDROME, Seminars in oncology, 20(6), 1993, pp. 1-5
Authors:
SEYMOUR JF
PIERCE SA
KANTARJIAN H
KEATING MJ
ESTEY EH
Citation: Jf. Seymour et al., NEURAL CELL-ADHESION MOLECULE (CD56) EXPRESSION IS ASSOCIATED WITH FAB SUBTYPE, CYTOGENETICS AND SKIN INFILTRATION IN ACUTE MYELOID-LEUKEMIA (AML), Blood, 82(10), 1993, pp. 10000126-10000126
Authors:
SEYMOUR JF
KURZROCK R
FREIREICH EJ
ESTEY EH
Citation: Jf. Seymour et al., PROLONGED CD4-CHLORODEOXYADENOSINE (2-CDA) IN PATIENTS (PTS) WITH HAIRY-CELL LEUKEMIA (HCL)( LYMPHOCYTOPENIA IS THE COST OF DURABLE RESPONSES TO 2), Blood, 82(10), 1993, pp. 10000142-10000142